# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-24-035953
Filing Date
2024-04-25
Accepted
2024-04-25 07:01:58
Documents
65
Period of Report
2024-04-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea0204620-8k_aldey.htm iXBRL | 8-K | 40030
2 | SLIDE PRESENTATION OF ALDEYRA THERAPEUTICS, INC. DATED APRIL 25, 2024. | ea020462001ex99-1_aldey.htm | EX-99.1 | 64877
3 | PRESS RELEASE OF ALDEYRA THERAPEUTICS, INC. DATED APRIL 25, 2024. | ea020462001ex99-2_aldey.htm | EX-99.2 | 15939
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 245935
5 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 173371
6 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 835001
7 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 298918
8 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 156981
9 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 361094
10 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 360634
11 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 295791
12 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 187129
13 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 406657
14 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 335683
15 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 394831
16 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 183813
17 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 292119
18 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 311742
19 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 164670
20 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 368726
21 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 210399
22 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 338393
23 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 158987
24 | GRAPHIC | ex99-1_021.jpg | GRAPHIC | 293840
25 | GRAPHIC | ex99-1_022.jpg | GRAPHIC | 250663
26 | GRAPHIC | ex99-1_023.jpg | GRAPHIC | 254563
27 | GRAPHIC | ex99-1_024.jpg | GRAPHIC | 684237
28 | GRAPHIC | ex99-1_025.jpg | GRAPHIC | 296043
29 | GRAPHIC | ex99-1_026.jpg | GRAPHIC | 335550
30 | GRAPHIC | ex99-1_027.jpg | GRAPHIC | 247607
31 | GRAPHIC | ex99-1_028.jpg | GRAPHIC | 163476
32 | GRAPHIC | ex99-1_029.jpg | GRAPHIC | 331805
33 | GRAPHIC | ex99-1_030.jpg | GRAPHIC | 276056
34 | GRAPHIC | ex99-1_031.jpg | GRAPHIC | 164140
35 | GRAPHIC | ex99-1_032.jpg | GRAPHIC | 336716
36 | GRAPHIC | ex99-1_033.jpg | GRAPHIC | 259141
37 | GRAPHIC | ex99-1_034.jpg | GRAPHIC | 247924
38 | GRAPHIC | ex99-1_035.jpg | GRAPHIC | 269153
39 | GRAPHIC | ex99-1_036.jpg | GRAPHIC | 199156
40 | GRAPHIC | ex99-1_037.jpg | GRAPHIC | 170525
41 | GRAPHIC | ex99-1_038.jpg | GRAPHIC | 184786
42 | GRAPHIC | ex99-1_039.jpg | GRAPHIC | 418612
43 | GRAPHIC | ex99-1_040.jpg | GRAPHIC | 416281
44 | GRAPHIC | ex99-1_041.jpg | GRAPHIC | 294673
45 | GRAPHIC | ex99-1_042.jpg | GRAPHIC | 299892
46 | GRAPHIC | ex99-1_043.jpg | GRAPHIC | 283475
47 | GRAPHIC | ex99-1_044.jpg | GRAPHIC | 412920
48 | GRAPHIC | ex99-1_045.jpg | GRAPHIC | 316222
49 | GRAPHIC | ex99-1_046.jpg | GRAPHIC | 303222
50 | GRAPHIC | ex99-1_047.jpg | GRAPHIC | 167560
51 | GRAPHIC | ex99-1_048.jpg | GRAPHIC | 445470
52 | GRAPHIC | ex99-1_049.jpg | GRAPHIC | 399084
53 | GRAPHIC | ex99-1_050.jpg | GRAPHIC | 159018
| Complete submission text file | 0001213900-24-035953.txt |  | 20926006

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
54 | XBRL SCHEMA FILE | aldx-20240425.xsd | EX-101.SCH | 3012
55 | XBRL LABEL FILE | aldx-20240425_lab.xml | EX-101.LAB | 34240
56 | XBRL PRESENTATION FILE | aldx-20240425_pre.xml | EX-101.PRE | 22357
68 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0204620-8k_aldey_htm.xml | XML | 3694

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 24872839
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)